COMPANY
Signpath Pharma
Timeline
- Trial start Phase 1/Phase 2: Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas source ↗
- Trial start IB: A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer source ↗
- Trial start Phase 1: Evaluation of Liposomal Curcumin in Healthy Volunteers source ↗
Clinical trials (lead sponsor) 3
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05768919 | Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas | Phase 1/Phase 2 | Recruiting | Mar 3, 2023 | 2026-02 (estimated) |
| NCT02138955 | A Phase IB Dose Escalation Study of Lipocurc in Patients With Cancer | IB | Completed | 2014-03 | Nov 30, 2017 (actual) |
| NCT01403545 | Evaluation of Liposomal Curcumin in Healthy Volunteers | Phase 1 | Completed | 2011-08 | 2012-08 (actual) |